Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 14 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2025 Filed Mar 14, 2025 21:39 UTC |
Wagner ScottDirector
|
GiftClass A Common Stock | 64,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 3 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,154 F3 · kind: Represents a gift of shares directly held by the Reporting Person to the Avery J. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:39 UTC |
Wagner ScottDirector
|
GiftClass A Common Stock | 64,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,386 F2 · kind: Represents a gift of shares directly held by the Reporting Person to the Drew S. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:39 UTC |
Wagner ScottDirector
|
GiftClass A Common Stock | 64,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000051 · wk-form4_1741988364.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,618 F1 · kind: Represents a gift of shares directly held by the Reporting Person to the Charles W. Wagner 2012 Irrevocable Trust for estate planning purposes. Following the transaction, the reporting person has neither investment control over nor a pecuniary interest in the transferred shares. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,787 Underlying: Class A Common Stock · 2,233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,205 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 808 | $4.61 | $3,724.88 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,874 Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 2,233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 4,191 | $4.61 | $19,320.51 |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,449 Read SEC document |
| March 08, 2025 Filed Mar 10, 2025 17:06 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000050 · wk-form4_1741640810.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:11 UTC |
Nabiey RominChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 114,507 | $0.00 Strike: $4.94 | $0.00 |
DisclosureSEC source: 0001809519-25-000048 · wk-form4_1741385459.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,507 Underlying: Class A Common Stock · 114,507 shares Expires 2035-03-05 F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on May 15, 2025 with the remaining 93.75% underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 17:11 UTC |
Nabiey RominChief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 76,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000048 · wk-form4_1741385459.xml · derivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,866 Underlying: Class A Common Stock · 76,866 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on May 15, 2025 and the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:46 UTC |
Barnes Wendy LynnDirector · See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 2,828,232 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 3 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,828,232 Underlying: Class A Common Stock · 2,828,232 shares Expires 2035-03-03 F4 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to early exercise and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:46 UTC |
Barnes Wendy LynnDirector · See Remarks
|
GrantRestricted Stock Unit · Derivative | 409,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 2 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,416 Underlying: Class A Common Stock · 409,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% underlying shares to vest in approximately equal quarterly installments thereafter for 4 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% underlying shares to vest in approximately equal quarterly installments thereafter for 4 quarters. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:46 UTC |
Barnes Wendy LynnDirector · See Remarks
|
GrantRestricted Stock Unit · Derivative | 1,842,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 1 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,842,374 Underlying: Class A Common Stock · 1,842,374 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:47 UTC |
McGinnis Christopher ASee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 1,096,937 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001809519-25-000046 · wk-form4_1741214861.xml · derivative · entry 2 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,096,937 Underlying: Class A Common Stock · 1,096,937 shares Expires 2035-03-03 F3 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:47 UTC |
McGinnis Christopher ASee Remarks
|
GrantRestricted Stock Unit · Derivative | 716,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000046 · wk-form4_1741214861.xml · derivative · entry 1 McGinnis Christopher A · CIK 0001652479 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716,479 Underlying: Class A Common Stock · 716,479 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on February 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 17:56 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,965 Underlying: Class A Common Stock · 12,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 17:56 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 5,202 | $4.84 | $25,177.68 |
DisclosureSEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,439 Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 17:56 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 12,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000024 · wk-form4_1739314569.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:15 UTC |
Wagner ScottDirector
|
GrantDeferred Stock Unit · Derivative | 94,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,182 Underlying: Class A Common Stock · 94,182 shares Expires not disclosed F4 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Class A common stock. F5 · derivative.exercise_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). F5 · derivative.expiration_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on January 21, 2026, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:15 UTC |
Wagner ScottDirector
|
GrantClass A Common Stock | 19,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,850 F2 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:15 UTC |
Wagner ScottDirector
|
GrantClass A Common Stock | 9,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000016 · wk-form4_1737670511.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,633 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 17:56 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 17:56 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 1,071 | $4.15 | $4,444.65 |
DisclosureSEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,979 Read SEC document |
| January 15, 2025 Filed Jan 15, 2025 17:56 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000010 · wk-form4_1736981776.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 18:43 UTC |
Voermann KarstenChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 89,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,876 Underlying: Class A Common Stock · 89,292 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 18:43 UTC |
Voermann KarstenChief Financial Officer
|
Tax withholdingClass A Common Stock | 29,035 | $4.41 | $128,044.35 |
DisclosureSEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,561 Read SEC document |
| January 08, 2025 Filed Jan 8, 2025 18:43 UTC |
Voermann KarstenChief Financial Officer
|
Exercise / conversionClass A Common Stock | 89,292 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-25-000008 · wk-form4_1736379800.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:09 UTC |
Hirsch Douglas JosephDirector
|
GrantClass A Common Stock | 6,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000004 · wk-form4_1735949341.xml · nonDerivative · entry 1 Hirsch Douglas Joseph · CIK 0001822522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,338 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2028; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| January 01, 2025 Filed Jan 4, 2025 00:07 UTC |
Bruehlman Ronald EDirector
|
GrantClass A Common Stock | 10,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000002 · wk-form4_1735949262.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,284 F1 · shares: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| December 21, 2024 Filed Dec 23, 2024 22:31 UTC |
Kennedy Kelly J.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 23,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000235 · wk-form4_1734993065.xml · derivative · entry 2 Kennedy Kelly J. · CIK 0001545591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,298 Underlying: Class A Common Stock · 23,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on December 21, 2024, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on December 21, 2024, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date. Read SEC document |
| December 21, 2024 Filed Dec 23, 2024 22:31 UTC |
Kennedy Kelly J.Director
|
Exercise / conversionClass A Common Stock | 23,150 | $4.44 | $102,786.00 |
DisclosureSEC source: 0001809519-24-000235 · wk-form4_1734993065.xml · nonDerivative · entry 1 Kennedy Kelly J. · CIK 0001545591 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,020 Underlying: Class A Common Stock · 2,232 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · derivative · entry 5 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,406 Underlying: Class A Common Stock · 10,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 797 | $4.91 | $3,913.27 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,444 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 2,232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,241 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 3,640 | $4.91 | $17,872.40 |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,009 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:36 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 10,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000206 · wk-form4_1733787371.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:39 UTC |
Voermann KarstenChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 54,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · derivative · entry 3 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,448 Underlying: Class A Common Stock · 54,064 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:39 UTC |
Voermann KarstenChief Financial Officer
|
Tax withholdingClass A Common Stock | 24,659 | $4.91 | $121,075.69 |
DisclosureSEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · nonDerivative · entry 2 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,304 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 18:39 UTC |
Voermann KarstenChief Financial Officer
|
Exercise / conversionClass A Common Stock | 54,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000208 · wk-form4_1733787554.xml · nonDerivative · entry 1 Voermann Karsten · CIK 0001822140 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 23:43 UTC |
Wagner ScottSee Remarks
|
Exercise / conversionRestricted Stock Unit · Derivative | 70,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · derivative · entry 4 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 70,591 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. F3 · derivative.expiration_date: The restricted stock unit award will vest in approximately equal monthly installments over eight months beginning on May 8, 2024, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 23:43 UTC |
Wagner ScottSee Remarks
|
Tax withholdingClass A Common Stock | 35,776 | $4.91 | $175,660.16 |
DisclosureSEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · nonDerivative · entry 2 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,109 Read SEC document |
| December 08, 2024 Filed Dec 9, 2024 23:43 UTC |
Wagner ScottSee Remarks
|
Exercise / conversionClass A Common Stock | 70,591 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000210 · wk-form4_1733787775.xml · nonDerivative · entry 1 Wagner Scott · CIK 0001342655 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 324,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 17:36 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,627 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 17:36 UTC |
Nabiey RominChief Accounting Officer
|
Tax withholdingClass A Common Stock | 4,519 | $5.04 | $22,775.76 |
DisclosureSEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,449 Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 17:36 UTC |
Nabiey RominChief Accounting Officer
|
Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000198 · wk-form4_1731450988.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:39 UTC |
Bruehlman Ronald EDirector
|
GrantDeferred Stock Unit · Derivative | 65,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000202 · wk-form4_1731451158.xml · derivative · entry 3 Bruehlman Ronald E · CIK 0001604076 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,075 Underlying: Class A Common Stock · 65,075 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). F4 · derivative.expiration_date: The deferred stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on November 8, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:39 UTC |
Bruehlman Ronald EDirector
|
GrantClass A Common Stock | 20,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000202 · wk-form4_1731451158.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,631 F2 · balance_after: Reflects deferred stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 22:39 UTC |
Bruehlman Ronald EDirector
|
GrantClass A Common Stock | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000202 · wk-form4_1731451158.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,128 F1 · balance_after: Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments on the last calendar day for each remaining month of the 2024 calendar year, beginning on November 30, 2024, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.